CLINACIN 25 MGML VETERINARY ORAL SOLUTION FOR CATS AND DOGS

Kraj: Izrael

Język: angielski

Źródło: Ministry of Health

Składnik aktywny:

CLINDAMYCIN AS HYDROCHLORIDE

Dostępny od:

A.L. MEDI-MARKET LTD.

Forma farmaceutyczna:

SOLUTION (ORAL)

Skład:

CLINDAMYCIN AS HYDROCHLORIDE 25 MG / 1 ML

Droga podania:

PER OS

Typ recepty:

Not required

Wyprodukowano przez:

CHANELLE PHARMACEUTICALS MANUFACTURING LTD., IRELAND

Wskazania:

Cats:For the treatment of infected wounds and abscesses caused by clindamycin-sensitive species of Staphylococcus spp. and Streptococcus spp.Dogs:- For the treatment of infected wounds, abscesses and oral cavity/dental infections caued by or associated with clindamycin-sensitive species of Staphylococcus spp., Streptococcus spp., Bacteroides spp., Fusobacterium necrophorum, Clostridium perfringens.- Adjuctive treatment of mechanical or surgical periodontal therapy in the treatment of infections of the gingival and periodontal tissues.For the treatment of osteomyelitis caused by Staphylococcus aureus.

Data autoryzacji:

2022-06-30

Charakterystyka produktu

THIS LEAFLET FORMAT WAS DETERMINED BY THE MINISTRY OF HEALTH AND THE
CONTENT
THEREOF WAS CHECKED AND APPROVED IN
JULY 2017
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Clinacin 25 mg/ml oral solution for cats and dogs.
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
One ml contains:
ACTIVE SUBSTANCE:
Clindamycin
25 mg
(as Clindamycin Hydrochloride 27.15 mg)
EXCIPIENTS:
Ethanol 96%
90.56 mg
For the full list of excipients see section 6.1.
3.
PHARMACEUTICAL FORM
Oral solution.
Clear, colourless solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cats and dogs.
4.2
INDICATIONS FOR USE (SPECIFYING THE TARGET SPECIES)
Cats:
For the treatment of infected wounds and abscesses caused by
clindamycin-sensitive species
of
_Staphylococcus_
spp. and
_Streptococcus_
spp.
Dogs:
-
For the treatment of infected wounds, abscesses and oral cavity/dental
infections caused
by or associated with clindamycin-sensitive species of
_Staphylococcus _
spp.,
_Streptococcus_
spp.,
_Bacteroides _
spp.,
_ Clostridium perfringens,_
_Fusobacterium _
_necrophorum_
.
-
Adjunctive treatment of mechanical or surgical periodontal therapy in
the treatment of
infections of the gingival and periodontal tissues.
-
For the treatment of osteomyelitis caused by
_Staphylococcus aureus_
.
4.3
CONTRA-INDICATIONS
Do not use in rabbits, hamsters, guinea pigs, chinchillas, horses or
ruminants because ingestion
of clindamycin by these species may cause severe gastro-intestinal
disorders,
that can
sometimes be fatal
.
Do not use in cases of hypersensitivity to either clindamycin or
lincomycin, or to any of the
excipients.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Inappropriate use of the product may increase the prevalence of
bacteria resistant to
clindamycin. Whenever possible, clindamycin should only be used based
on susceptibility
testing.
Official national and local antimicrobial policies should be taken
into account when the
product is used.
Clindamyci